Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORIAMI: Oral Antibiotics in Acute Mesenteric Ischemia
NCT06387147Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2025
- Primary completion
- Nov 2027
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 3 trial of gentamicin, metronidazole in acute mesenteric ischemia (AMI), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2025; status: recruiting.
02
Drugs
gentamicinmetronidazole
03
Conditions
acute mesenteric ischemia (AMI)
Beyond the preview
Go deeper on NCT06387147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06387147.